您搜索了: neocolipor (丹麦语 - 英语)

neocolipor
neocolipor

hvad er neocolipor?
what is neocolipor?

handels -navn neocolipor
tradename neocolipor

neocolipor injektionsvæske, suspension
neocolipor suspension for injection

16/ 19 indlÆgsseddel neocolipor
15/ 18 package leaflet neocolipor

hvordan blev neocolipor undersøgt?
how has neocolipor been studied?

neocolipor epar - sammendrag for offentligheden
neocolipor epar summary for the public

hvilke bivirkninger er der ved neocolipor?
what are the side-effects of neocolipor?

neocolipor injektionsvæske, suspension.svin (søer og gylte)
neocolipor suspension for injection pigs (sows and gilts)

hvilken fordel viser undersøgelserne, der er ved neocolipor?
what benefit has neocolipor shown during the studies?

neocolipor er en inaktiveret vaccine med aluminiumhydroxid som adjuvans og thiomersal som konserveringsmiddel.
neocolipor is an inactivated vaccine with aluminium hydroxide as adjuvant and thiomersal as a preservative.

neocolipor gives til søer (både søer og gylte) for at immunisere deres afkom over for neonatal enterotoxicose.
neocolipor is administered to female pigs – both sows and gilts - in order to immunise their offspring against neonatal enterotoxicosis.

europa-kommissionen udstedte en markedsføringstilladelse med gyldighed i hele den europæiske union for neocolipor til mérial den 9. august 2002.
the european commission granted a marketing authorisation, valid throughout the european union, for neocolipor to mérial on 9 august 2002.

neocolipor er en inaktiveret vaccine beregnet til at reducere neonatal enterotoxicose (en bakterieinfektion forårsaget af stammer af e. coli) hos pattegrise.
neocolipor is an inactivated vaccine intended to be used to reduce neonatal enterotoxicosis (a bacterial infection caused by strains of e.coli) in very young piglets.

udvalget for veterinærlægemidler (cvmp) konkluderede, at det i overensstemmelse med eu-kravene er blevet påvist, at neocolipor er effektiv til reduktion af neonatal enterotoxicose hos pattegrise.
the committee for medicinal products for veterinary use (cvmp) considered that, in accordance with european union requirements, neocolipor had been shown to be effective in the reduction of neonatal enterotoxicosis in piglets.

der kunne udstedes en ef-markedsføringstilladelse for neocolipor via det centraliserede system, idet lægemidlet fremstilles ved rekombinant dna-teknoligi, og således er omfattet af del a i bilaget til rådets forordning (eØf) nr.2309/93.
neocolipor was eligible for the granting of a community marketing authorisation via the centralised system as it was developed using recombinant dna technology and hence qualified under part a of the annex to council regulation (eec) no 2309/93.